On January 27, 2026, the Delaware Supreme Court issued a significant pro-policyholder decision affirming that directors and officers (“D&O”) insurers must cover a $28 million settlement paid by Harman International Industries Inc., to resolve stockholder litigation arising from its multi-billion dollar sale to Samsung Electronics Co., Ltd. The Court affirmed the Superior Court’s ruling that
Healthcare & Life Sciences Private Equity Deal Tracker: Arcline to Sell Resolution Medical to Resonetics
Arcline Investment Management has announced it will sell Resolution Medical to Resonetics.
Resolution Medical, founded in 2012 and based in Fridley, Minnesota, is an engineering services and outsourced manufacturing company focused on complex Class II and III devices for areas including structural heart, cardiology and vascular, electrophysiology and neuromodulation therapies.
Arcline, founded in
Healthcare & Life Sciences Private Equity Deal Tracker: J.P. Morgan Life Sciences Invests in Turbett Surgical
J.P. Morgan Life Sciences Private Capital has invested in Turbett Surgical, according to a news release.
Turbett, founded in 2013 and based in Henrietta, New York, is a medical equipment company that manufactures mobile sterilization pods and consumable filters for surgical equipment sterilization.
J.P. Morgan Life Sciences Private Capital is the life sciences
Healthcare & Life Sciences Private Equity Deal Tracker: Main Post Acquires HomeWell Care Services
Main Post Partners has announced its acquisition of HomeWell Care Services.
HomeWell, founded in 2002 and based in Burkburnett, Texas, is a franchise home care provider with more than 100 franchise owners across the United States.
Main Post, founded in 2014 and based in San Francisco, is a middle market private equity firm
Data Privacy Day 2026: What Changed on Jan. 1 — And What to Watch Next
Data Privacy Day offers a natural checkpoint to take stock of a fast‑moving legal landscape. As of January 1, 2026, several significant U.S. state privacy laws and regulatory updates are now live, with additional U.S. and global milestones queued up throughout 2026. Below we summarize important changes already in effect and highlight issues to monitor as the year unfolds.
FDA and EMA Provide Guiding Principles for AI in Drug Development
On Jan. 14, 2026, the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) jointly released the “Guiding Principles of Good AI Practice in Drug Development,” a set of 10 high-level principles intended to steer the safe and responsible use of AI across the product lifecycle. While not formal industry guidance, the
Healthcare & Life Sciences Private Equity Deal Tracker: Water Street Acquires Pillr From Renovus
Water Street Healthcare Partners has acquired Pillr Health from Renovus Capital Partners, according to a news release.
Pillr, founded in 2003 and based in Boca Raton, Florida, is a provider of software and tech-enabled pharmacy solutions.
Water Street, founded in 2005 and based in Chicago, is a private equity firm focused exclusively
New Mountain Closes New Fund With $1.2 Billion
New Mountain Capital announced the closing of its second non-control private equity fund.
The fund, New Mountain Strategic Equity Fund II, closed at $1.2 billion, exceeding its hard cap of $1 billion.
New Mountain, founded in 1999 and based in New York, is a growth-oriented investment firm. Areas of focus for the firm include
DoW Announces Line-by-Line Review of Certain 8(a) Contracts Amid Government-wide Scrutiny of the 8(a) Program
On January 16, 2026, the Secretary of War Pete Hegseth posted a video on social media announcing that the Department of War will conduct a “line‑by‑line review of every small business, sole source, 8(a) contract that is over $20 million,” focusing on impermissible pass‑throughs to large businesses. This action by the DoW aligns with broader federal investigations and audits of the 8(a) program.
Healthcare & Life Sciences Private Equity Deal Tracker: Lead Capital Invests in PedsOne
Lead Capital Partners (LCP) has announced an investment in PedsOne.
PedsOne, founded in 2011 and based in Nashville, Tennessee, is a provider of outsourced revenue cycle management and consulting services to independent pediatric practices throughout the United States.
LCP, founded in 2011 and based in Nashville, Tennessee, is a lower middle market private